| 177Lu-DOTATATE for Recurrent Meningioma | Phase II | rekrutiert |
| A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Trea | Phase I / Phase II | rekrutiert |
| A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melano | Phase II | rekrutiert |
| A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-796 | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Saf | Phase I / Phase II | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patien | Phase III | rekrutiert |
| A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light | — | rekrutiert |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibros | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) | Phase III | rekrutiert |
| A Long-term Extension Study of PCI-32765 (Ibrutinib) | Phase III | rekrutiert |
| A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis | Phase II | rekrutiert |
| A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic L | Phase III | rekrutiert |
| A Mentalization Based Prevention Program to Foster Well-Being and Mental Health in Pre-Adolescen | ohne Phasenangabe | rekrutiert |
| A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Bask | Phase II | rekrutiert |
| A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Co | Phase II / Phase III | rekrutiert |
| A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves | — | rekrutiert |
| A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tube | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis | Phase II | rekrutiert |
| A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Diseas | Phase II | rekrutiert |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With | Phase III | rekrutiert |
| A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodi | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart | Phase III | rekrutiert |
| A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestra | Phase II | rekrutiert |
| A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatr | Phase II | rekrutiert |
| A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Sa | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of | Phase III | rekrutiert |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | Phase II | rekrutiert |
| A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | Frühe Phase I | rekrutiert |
| A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With | ohne Phasenangabe | rekrutiert |
| A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Sup | ohne Phasenangabe | rekrutiert |
| A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in Pe | Phase II | rekrutiert |
| A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function | Phase II | rekrutiert |
| A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antib | Phase III | rekrutiert |
| A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa | Phase II / Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs | Phase III | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Particip | Phase I / Phase II | rekrutiert |
| A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With | Phase III | rekrutiert |
| A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First | Phase III | rekrutiert |
| A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic | Phase III | rekrutiert |
| A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors | Phase I / Phase II | rekrutiert |
| A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Adva | Phase II | rekrutiert |
| A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiop | Phase III | rekrutiert |
| A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin | — | rekrutiert |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagn | Phase III | rekrutiert |
| A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With | Phase I | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treate | — | rekrutiert |
| A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer | Phase I / Phase II | rekrutiert |
| A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in P | Phase III | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Phase II / Phase III | rekrutiert |
| A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neop | Phase I | rekrutiert |
| A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring | Phase I / Phase II | rekrutiert |
| A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | Phase III | rekrutiert |
| A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Meta | Phase III | rekrutiert |
| A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cance | Phase III | rekrutiert |
| A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants Wi | Phase III | rekrutiert |
| A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory M | — | rekrutiert |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, | Phase I / Phase II | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Pati | Phase III | rekrutiert |
| A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma | Phase II | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemot | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy | Phase II | rekrutiert |
| A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 | Phase I | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzuma | Phase II / Phase III | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in | Phase I / Phase II | rekrutiert |
| A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma | Phase I | rekrutiert |
| A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin | Phase III | rekrutiert |
| A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF | Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO | Phase III | rekrutiert |
| A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Pa | Phase III | rekrutiert |
| A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of The | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combi | Phase III | rekrutiert |
| A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary | Phase I / Phase II | rekrutiert |
| A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 | Phase III | rekrutiert |
| A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients W | Phase II | rekrutiert |
| A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progr | Phase II | rekrutiert |
| A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplan | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Re | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants Wi | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sc | Phase III | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Ey | ohne Phasenangabe | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Migl | Phase III | rekrutiert |
| A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With | Phase III | rekrutiert |
| A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Foc | Phase III | rekrutiert |
| A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adul | Phase III | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Par | Phase III | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared | Phase III | rekrutiert |
| A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sep | Phase II | rekrutiert |
| A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis | — | rekrutiert |
| A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Neph | Phase III | rekrutiert |
| A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial | Phase II | rekrutiert |
| A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult | Phase III | rekrutiert |
| A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants | Phase I / Phase II | rekrutiert |
| A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyr | — | rekrutiert |
| A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Tak | Phase III | rekrutiert |
| A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How i | Phase III | rekrutiert |
| A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Ca | Phase II | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis | Phase III | rekrutiert |
| A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD | Phase II | rekrutiert |
| A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma | Phase II / Phase III | rekrutiert |
| A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-ob | Phase II | rekrutiert |
| ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliom | Phase II | rekrutiert |
| ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or | Phase I / Phase II | rekrutiert |
| ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants Wi | Phase II | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple My | Phase I / Phase II | rekrutiert |
| Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptom | Phase III | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At | Phase II | rekrutiert |
| Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation | Phase II | rekrutiert |
| Adjuvant Tebentafusp in High Risk Ocular Melanoma | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| Ambulatory Stroke Unit Treatment for Elderly Patients | ohne Phasenangabe | rekrutiert |
| An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients Wi | ohne Phasenangabe | rekrutiert |
| An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects | — | rekrutiert |
| An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaem | Phase III | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase III | rekrutiert |
| Apnoeic Oxygenation During Pediatric Tracheal Intubation | ohne Phasenangabe | rekrutiert |
| Assessing Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON Endostapler | — | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Atypical Hemolytic-Uremic Syndrome (aHUS) Registry | — | rekrutiert |
| Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positi | ohne Phasenangabe | rekrutiert |
| BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation | ohne Phasenangabe | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small | Phase II | rekrutiert |
| Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected St | Phase III | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. | Phase II | rekrutiert |
| CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer | — | rekrutiert |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer | — | rekrutiert |
| Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-N | ohne Phasenangabe | rekrutiert |
| Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Ad | Phase III | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Performance of Long-span Fixed Partial Dentures | ohne Phasenangabe | rekrutiert |
| Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients | Phase III | rekrutiert |
| Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation | Phase II | rekrutiert |
| Cohort Study on Plant-based Diets (COPLANT Study) | — | rekrutiert |
| ColoCare Study - Colorectal Cancer Cohort | — | rekrutiert |
| Colorectal Resections in Patients With Retroperitoneal Sarcoma | — | rekrutiert |
| Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refrac | Phase I / Phase II | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Ca | ohne Phasenangabe | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Corheart 6 LVAS Study | ohne Phasenangabe | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig P | Phase III | rekrutiert |
| DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to C | Phase III | rekrutiert |
| DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis | ohne Phasenangabe | rekrutiert |
| DV 100 as a Framework for the Hospital Incident Command System | — | rekrutiert |
| DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardio | — | rekrutiert |
| Dabrafenib and/or Trametinib Rollover Study | Phase IV | rekrutiert |
| De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcino | ohne Phasenangabe | rekrutiert |
| Digital Home-Based Physical Activity Promotion for Older Adults After Total Hip Arthroplasty | ohne Phasenangabe | rekrutiert |
| Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis | Phase II | rekrutiert |
| Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke | ohne Phasenangabe | rekrutiert |
| Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody | Phase III | rekrutiert |
| Effect of Fetal Aortic Valvuloplasty on Outcomes | — | rekrutiert |
| Effectiveness of an Ecological Momentary Emotion Regulation Intervention | ohne Phasenangabe | rekrutiert |
| Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moder | Phase II | rekrutiert |
| Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease | — | rekrutiert |
| Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients | Phase II | rekrutiert |
| Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease | Phase II | rekrutiert |
| Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients W | Phase II / Phase III | rekrutiert |
| Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With | Phase III | rekrutiert |
| Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HF | Phase II | rekrutiert |
| Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therap | Phase III | rekrutiert |
| Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock | ohne Phasenangabe | rekrutiert |
| Efficacy of INM004 in Children With STEC-HUS | Phase III | rekrutiert |
| Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failur | Phase II / Phase III | rekrutiert |
| Empowering Patients to Improve Safety in Polymedication | ohne Phasenangabe | rekrutiert |
| Endothelial Dysfunction for Prognosis In Patients With preeClampSia | — | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluation Of Outcomes Following Rotator Cuff Repair Using the REGENETEN Bioinductive Implant | — | rekrutiert |
| Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell | Phase II | rekrutiert |
| Evaluation of Optical Coherence Tomography in Dentistry | ohne Phasenangabe | rekrutiert |
| Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Mo | ohne Phasenangabe | rekrutiert |
| Exploring the Effects of Exercise on Memory and Cognition in Parkinson´s Disease | ohne Phasenangabe | rekrutiert |
| Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Pa | ohne Phasenangabe | rekrutiert |
| Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Pa | Phase II | rekrutiert |
| Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FL | Phase II | rekrutiert |
| Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk | ohne Phasenangabe | rekrutiert |
| Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FAS | Phase III | rekrutiert |
| Functional MRI for Monitoring Progression and Assessing Trends in ILD | ohne Phasenangabe | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 | Phase II | rekrutiert |
| Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITIO | Phase II | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| Glioblastoma Radiotherapy Using IMRT or Proton Beams | ohne Phasenangabe | rekrutiert |
| Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children a | — | rekrutiert |
| Global Registry and Natural History Study for Mitochondrial Disorders | — | rekrutiert |
| HOPE Against Cancer Recurrence in HCC | Phase IV | rekrutiert |
| Heidelberg Registry for Hip and Knee Joint Implants and Revisions | — | rekrutiert |
| Heidelberg Study on Diabetes and Complications | — | rekrutiert |
| Hyperspectral Imaging for Prediction of Preeclampsia | — | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractor | Phase I / Phase II | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps | — | rekrutiert |
| Influence of Supine Positioning on the Outcomes After Descemet Membrane Endothelial Keratoplasty | ohne Phasenangabe | rekrutiert |
| Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surr | ohne Phasenangabe | rekrutiert |
| Intent of Surgery for IPMN | — | rekrutiert |
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phen | Phase III | rekrutiert |
| Intermittent Fasting to Improve Insulin Secretion | ohne Phasenangabe | rekrutiert |
| International (Pediatric) Peritoneal Biobank | — | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy | ohne Phasenangabe | rekrutiert |
| Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Pati | Phase I | rekrutiert |
| Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy | ohne Phasenangabe | rekrutiert |
| Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease ( | Phase I | rekrutiert |
| Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cel | Phase II | rekrutiert |
| JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors | — | rekrutiert |
| L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma | Phase II | rekrutiert |
| L19IL2/TNF in Patients With Basal Cell Carcinoma | Phase II | rekrutiert |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Cal | Phase III | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC | Phase III | rekrutiert |
| LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus | ohne Phasenangabe | rekrutiert |
| Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdi | — | rekrutiert |
| Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Pha | Phase III | rekrutiert |
| Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells | Phase II / Phase III | rekrutiert |
| Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRA | Phase III | rekrutiert |
| Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN | Phase III | rekrutiert |
| Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Follo | — | rekrutiert |
| Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion | Frühe Phase I | rekrutiert |